Showing 11,081 - 11,100 results of 24,537 for search '(( 50 ((ng decrease) OR (mean decrease)) ) OR ( 100 ((nm decrease) OR (a decrease)) ))', query time: 1.10s Refine Results
  1. 11081

    Image_2_The relationship between central obesity and risk of breast cancer: a dose–response meta-analysis of 7,989,315 women.jpg by Hongyang Chen (410527)

    Published 2023
    “…Regarding the BC subtype, central obesity is proven to be a risk of ER+ and ER- BCs. The dose–response analysis revealed that when BMI (during premenopausal) exceeded 23.40 kg/m<sup>2</sup>, the risk of BC began to decrease, and WC higher than 83.80 cm or WHR exceeded 0.78 could efficiently increase the BC risk.…”
  2. 11082

    Table_4_The relationship between central obesity and risk of breast cancer: a dose–response meta-analysis of 7,989,315 women.DOCX by Hongyang Chen (410527)

    Published 2023
    “…Regarding the BC subtype, central obesity is proven to be a risk of ER+ and ER- BCs. The dose–response analysis revealed that when BMI (during premenopausal) exceeded 23.40 kg/m<sup>2</sup>, the risk of BC began to decrease, and WC higher than 83.80 cm or WHR exceeded 0.78 could efficiently increase the BC risk.…”
  3. 11083

    Table_2_The relationship between central obesity and risk of breast cancer: a dose–response meta-analysis of 7,989,315 women.DOCX by Hongyang Chen (410527)

    Published 2023
    “…Regarding the BC subtype, central obesity is proven to be a risk of ER+ and ER- BCs. The dose–response analysis revealed that when BMI (during premenopausal) exceeded 23.40 kg/m<sup>2</sup>, the risk of BC began to decrease, and WC higher than 83.80 cm or WHR exceeded 0.78 could efficiently increase the BC risk.…”
  4. 11084

    Table_5_The relationship between central obesity and risk of breast cancer: a dose–response meta-analysis of 7,989,315 women.DOCX by Hongyang Chen (410527)

    Published 2023
    “…Regarding the BC subtype, central obesity is proven to be a risk of ER+ and ER- BCs. The dose–response analysis revealed that when BMI (during premenopausal) exceeded 23.40 kg/m<sup>2</sup>, the risk of BC began to decrease, and WC higher than 83.80 cm or WHR exceeded 0.78 could efficiently increase the BC risk.…”
  5. 11085

    MAP3K19 siRNA inhibits cigarette smoke-induced pulmonary inflammation. by Stefen A. Boehme (2657068)

    Published 2016
    “…<p>The acute model of cigarette smoke exposure subjected mice to cigarette smoke (7 cigarettes over a 1.75 hour period) on days 1 & 2, and dosed with either PBS, non-sense siRNA (100 μg in 50 μl volume), MAP3K19 siRNA or the CXCR-2 antagonist SB 265610 (10 mg/kg, p.o.) on days 1, 2 & 3 (n = 5 mice per treatment group). …”
  6. 11086

    Assessing the usage of end-of-life tire pyrolysis oil as an alternative fuel in a diesel engine in the point of energy, exergy, exergoeconomic, exergoenviroeconomic, and sustainabi... by Talha Ertürk (19715855)

    Published 2024
    “…<p>The present study examines the utilization of fuel blends comprising waste tire pyrolysis oil (WTPO) at varying ratios (10%, 20%, 30%, and 40%) in a compression-ignition (CI) engine at different loads (25%, 50%, 75%, and 100%). …”
  7. 11087

    ERR2/3 may in part operate through <i>Kcna10</i> to promote a gamma motor neuron-like biophysical signature. by Mudassar N. Khan (14290428)

    Published 2022
    “…<b>(C)</b> Reporter tdTomato fluorescence driven by wild-type (WT) <i>Kcna10</i> promoter is boosted by ERR2 cotransfection (red, <i>n</i> = 102) in chick motor neurons when compared to control (gray, <i>n</i> = 100) and decrease in tdTomato reporter fluorescence upon mutating the ERR2/3 binding sites (black, <i>n</i> = 101). …”
  8. 11088

    Do pheromone traps help to reduce new attacks of Ips typographus at the local scale after a sanitary cut ? Supplements and detailed statistical analysis by Gilles San Martin (3552875)

    Published 2022
    “…</p> <p>In this two-year study (2020-2021), at the peak of a severe outbreak in Belgium, we quantified the wood volume and presence/absence of new attacks at 126 sites attacked during the previous year and within 100 m from the initial attack. …”
  9. 11089

    CBP-1 is critical for <i>mir-80</i>(Δ) healthspan benefits, and is a candidate direct binding target of miR-80. by Mehul Vora (94793)

    Published 2013
    “…<p><a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1003737#pgen-1003737-g006" target="_blank">Fig. 6A</a>. …”
  10. 11090

    PrP<sup>C</sup>GPIThy-1 L150 mice show a delay to terminal disease and altered neuropathology upon prion infection. by Berta Puig (344828)

    Published 2019
    “…Chart underneath shows mean relative intensity of PrP referred to actin where WTPrP<sup>C</sup> samples are set to 100% as a reference (error bars are SEM; n = 5 for each genotype). …”
  11. 11091

    Effect of Selenite and Selenate Application on Mineral Composition of Lettuce Plants Cultivated Under Hydroponic Conditions: Nutritional Balance Overview Using a Multifaceted Study by Emanueli do Nascimento da Silva (3897079)

    Published 2018
    “…Selenate promoted the absorption of Mo and S and the reduction of K, Mn and P, meanwhile selenite increased Mn and decreased Mo accumulation. Copper and Fe absorption was negatively affected, Ca and Mg showed a slight increase, and Na and Zn were not affected by Se species. …”
  12. 11092

    Analysis of targeted MLX deletion in Sertoli cells. by Patrick A. Carroll (11586792)

    Published 2021
    “…<p>(<b>A</b>) IF for the Sertoli cell marker SOX9 in WT and MLX<sup>KO</sup> testes with acellular tubules indicated with asterisks (100×, scale bar = 400 uM). …”
  13. 11093

    Data_Sheet_3_An Evaluation of Three Ways of Communicating Carrier Status Results to the Parents of Children in a Neonatal Sickle Cell Screening Programme.PDF by Christelle Rémus (8995493)

    Published 2020
    “…</p><p>Method: In a randomized study, we contacted 300 couples of parents after their child had been identified as a SCD carrier in the French national newborn screening programme: 100 couples received an information letter (the standard procedure in France: arm A), 100 couples received a letter and then a follow-up phone call (arm B), and 100 received a letter and then three follow-up text messages at 5-day intervals (arm C). …”
  14. 11094

    Data_Sheet_1_An Evaluation of Three Ways of Communicating Carrier Status Results to the Parents of Children in a Neonatal Sickle Cell Screening Programme.PDF by Christelle Rémus (8995493)

    Published 2020
    “…</p><p>Method: In a randomized study, we contacted 300 couples of parents after their child had been identified as a SCD carrier in the French national newborn screening programme: 100 couples received an information letter (the standard procedure in France: arm A), 100 couples received a letter and then a follow-up phone call (arm B), and 100 received a letter and then three follow-up text messages at 5-day intervals (arm C). …”
  15. 11095

    Data_Sheet_2_An Evaluation of Three Ways of Communicating Carrier Status Results to the Parents of Children in a Neonatal Sickle Cell Screening Programme.PDF by Christelle Rémus (8995493)

    Published 2020
    “…</p><p>Method: In a randomized study, we contacted 300 couples of parents after their child had been identified as a SCD carrier in the French national newborn screening programme: 100 couples received an information letter (the standard procedure in France: arm A), 100 couples received a letter and then a follow-up phone call (arm B), and 100 received a letter and then three follow-up text messages at 5-day intervals (arm C). …”
  16. 11096

    Image4_The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis.JPEG by Paolo Comeglio (14195007)

    Published 2024
    “…Selvigaltin (previously known as GB1211) is a novel orally active galectin-3 small molecule inhibitor that has high affinity for galectin-3 (human K<sub>D</sub> = 25 nM; rabbit K<sub>D</sub> = 12 nM) and high oral bioavailability in rabbits and man. …”
  17. 11097

    Image6_The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis.JPEG by Paolo Comeglio (14195007)

    Published 2024
    “…Selvigaltin (previously known as GB1211) is a novel orally active galectin-3 small molecule inhibitor that has high affinity for galectin-3 (human K<sub>D</sub> = 25 nM; rabbit K<sub>D</sub> = 12 nM) and high oral bioavailability in rabbits and man. …”
  18. 11098

    Image3_The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis.JPEG by Paolo Comeglio (14195007)

    Published 2024
    “…Selvigaltin (previously known as GB1211) is a novel orally active galectin-3 small molecule inhibitor that has high affinity for galectin-3 (human K<sub>D</sub> = 25 nM; rabbit K<sub>D</sub> = 12 nM) and high oral bioavailability in rabbits and man. …”
  19. 11099

    Table2_The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis.DOCX by Paolo Comeglio (14195007)

    Published 2024
    “…Selvigaltin (previously known as GB1211) is a novel orally active galectin-3 small molecule inhibitor that has high affinity for galectin-3 (human K<sub>D</sub> = 25 nM; rabbit K<sub>D</sub> = 12 nM) and high oral bioavailability in rabbits and man. …”
  20. 11100

    Image1_The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis.JPEG by Paolo Comeglio (14195007)

    Published 2024
    “…Selvigaltin (previously known as GB1211) is a novel orally active galectin-3 small molecule inhibitor that has high affinity for galectin-3 (human K<sub>D</sub> = 25 nM; rabbit K<sub>D</sub> = 12 nM) and high oral bioavailability in rabbits and man. …”